With Armelle Cuvillier and Gaël Champier, 6 shareholders are part of B Cell Design's board of directors. They gather every three months to determine the future strategic position of the company. Moreover, members of this committee share their expertise and network with B Cell Design's team.
Chairman of the board of directors : Former administrative and financial director of Aventis, board member of Innate Pharma, former chairman of the board of Onxeo (formerly Alliance Pharma), board member of Shire Pharmaceutical. Patrick Langlois has an international experience of 30 years in health field. He has an expertise in pharmaceutical company development and strategy through its functions of financial director, group executive vice president and vice president of the board of Aventis S.A.
Members of the board
Bertrand Louvet is currently the president of the "Ecole Nationale Supérieure de Chimie" (Chemistry engineering school) in Rennes. He was the former director of Rhône Poulenc USA, director of the chemistry specialty of Rhône Poulenc, director of industry and security of Rhône Poulenc, president of "l'Union des Industries Chimiques" and vice-president of the tribunal of commerce of Nanterre.
Dr. Annick Schwebig
She previously worked at Bristol-Myers Squibb as France Medical Affairs Vice President and Europe R&D Vice president. Founder of the European subsidiary of Actelion, she became CEO, then secretary general of ARIIS (French Alliance for Research and Innovation in health Industry) where she also is Vice President of Biotech committee. She is President of rare diseases group president of Leem. She is Vice President of "Equilibre et populations" NGO, selected at CCIR Paris Ile de France, member of the management board of ESSEC business school. She is also Vice President of supervisory board of Inserm Transfer, member of the experts committee of Large Venture fund of BPI and administrator of Cellectis and Inventiva companies.
Pierre Lévi is the founder and manager of Metman Investissements. His experience as President of the "Salins du Midi", and as CEO of Faurecia will be helpful during the industrial development steps of the company.
Jean-François Macquin has about 35 years of experience in the industry.
He started his career in IBM. After that, he joined Rhône-Poulenc where he was successively economical director of chemistry specialties, strategy and planning director then IT organisation director of Rhone-Poulenc Chemistry. He was also director of Intermines Paris.